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Abstract
Background: The al-Andalus physical activity intervention study is a randomised control trial to investigate the
effectiveness of a land- and water-based exercise intervention for reducing the overall impact of fibromyalgia
(primary outcome), and for improving tenderness and pain-related measures, body composition, functional
capacity, physical activity and sedentary behaviour, fatigue, sleep quality, health-related quality of life, and cognitive
function (secondary outcomes) in women with fibromyalgia.
Methods/Design: One hundred eighty women with fibromyalgia (age range: 35-65 years) will be recruited from local
associations of fibromyalgia patients in Andalucía (Southern Spain). Patients will be randomly assigned to a usual care
(control) group (n = 60), a water-based exercise intervention group (n = 60) or a land-based exercise intervention group
(n = 60). Participants in the usual care group will receive general physical activity guidelines and participants allocated
in the intervention groups will attend three non-consecutive training sessions (60 min each) per week during 24 weeks.
Both exercise interventions will consist of aerobic, muscular strength and flexibility exercises. We will also study the
effect of a detraining period (i.e., 12 weeks with no exercise intervention) on the studied variables.
Discussion: Our study attempts to reduce the impact of fibromyalgia and improve patients’ health status by
implementing two types of exercise interventions. Results from this study will help to assess the efficacy of exercise
interventions for the treatment of fibromyalgia. If the interventions would be effective, this study will provide low-
cost and feasible alternatives for health professionals in the management of fibromyalgia. Results from the al-
Andalus physical activity intervention will help to better understand the potential of regular physical activity for
improving the well-being of women with fibromyalgia.
Trial registration: ClinicalTrials.gov ID: NCT01490281
Background
Fibromyalgia is becoming a common syndrome in Wes-
tern European countries since a point prevalence of
2.9% would translate to approximately 6 million people
with fibromyalgia [1]. The prevalence of fibromyalgia in
Spain is ~2.4%, and is more common in women (~4.2%)
than in men (~0.2%) [2].
Fibromyalgia is considered a disorder of pain regula-
tion [3], as indicated by an increased sensitivity to pain-
ful stimuli (hyperalgesia) and lowered pain threshold
(allodynia) [4]. Additionally to pain, fibromyalgia symp-
toms typically include fatigue, stiffness, non-restorative
sleep patterns, and memory and cognitive difficulties
[5-7]. Other common symptoms are low back pain,
recurrent headaches, muscle-spasm, and balance
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patients diagnosed with fibromyalgia is very high [8],
which increases patients’ needs for appropriate medical
management and results in higher healthcare resource
utilization compared with persons without fibromyalgia
[9].
Fibromyalgia has an important impact on the patients’
health-related quality of life [10,11], since it limits activ-
ities of daily life such as walking or raising and trans-
porting objects [11,12]. In general, functional capacity is
decreased in adults with fibromyalgia [13-18] and is
similar to that of healthy elderly [16,19]. Jones et al. [19]
reported that women with fibromyalgia have difficulties
for staying physically independent.
Exercise therapy is relatively economical, easily acces-
sible and widely used in clinical practice as a strategy
for pain management. Several reviews concerning the
effect of exercise in fibromyalgia patients concluded
that: i) there is moderate evidence that aerobic exercise
produces important benefits in physical function, pain
and tender points [20,21]; ii) there is limited evidence
that strength training improves pain, global wellbeing,
physical function, tender points and depression [22];
a n di i i )t h e r ei sn o te n o u g he v i d e n c er e g a r d i n gt h e
health-related effects of flexibility exercises [22]. A
recent meta-analysis [23] concluded that exercise (aero-
bic, strength training or both) improves global well-
being, assessed by the fibromyalgia impact questionnaire
(FIQ) in women with fibromyalgia. The Ottawa Panel
supports the use of aerobic exercise interventions and
strengthening exercises for the overall management of
fibromyalgia [24,25].
Exercise therapy in fibromyalgia patients has usually
focused on either pool or land-based exercises. A recent
meta-analysis [26] indicated that there is no evidence
that water-based aerobic exercise produces superior
results compared to similarly intense land-based exer-
cise. Others narrative reviews however suggested slight
additional benefits for water-based aerobic exercise on
reducing pain and improving depressive symptoms [27],
sleep quality and mood [20]. Jentoff et al. [28] compared
the effect of a 20-week pool-based exercise and a land-
based exercise intervention (twice a week) on symptoms,
self-efficacy, self-reported physical impairment, and phy-
sical capacity in a group of fibromyalgia patients. They
observed significant improvements in cardiovascular
capacity and walking time in both exercise groups. The
pool-exercise group also improved self-reported physical
impairment, number of days feeling good, pain, anxiety,
and depression. To our knowledge, the study by Jentoff
et al. [28] is the only available study investigating the
possible additional beneficial effects of exercising in a
warm-water pool (compared to land-based) in fibro-
myalgia patients. More studies comparing the effectives
of a water-based exercise program with a land-based
exercise intervention on a broader range of physical and
psychological outcomes and with longer intervention
period, higher frequency, and larger samples are needed.
It is of public health and clinical relevance to better
understand whether the benefits of land-based exercise
are similar to those observed with exercise undertaken
in water, owing to the low availability of pools with an
appropriate water temperature for these patients, ideally
between 30 and 33°C.
Objectives
The primary objective of the al-Andalus physical activity
randomised controlled trial (RCT) is to investigate the
effectiveness of two types of exercise interventions
(water- and land-based aerobic-strength training vs. a
control group) on the overall impact of fibromyalgia
(primary outcome), and on tenderness and pain-related
measures, body composition, functional capacity, physi-
cal activity and sedentary behaviour, fatigue, sleep qual-
ity, health-related quality of life and cognitive function
(secondary outcomes) in women aged 35-65 years with
fibromyalgia. The intervention groups will train 3 days/
week (60 min per session) for a 24-week period. We will
also study the effect of a detraining period (i.e., 12
weeks with no exercise intervention) on the studied
variables.
Presentation of the hypothesis
We hypothesised that: (i) a 24-weeks exercise interven-
tion training (either water- or land-based) would be
effective for reducing the impact of fibromyalgia (pri-
mary outcome), and improving tenderness and pain-
related measures, body composition, functional capacity,
physical activity and sedentary behaviour, fatigue, sleep
quality, health-related quality of life and cognitive func-
tion (secondary outcomes) in women with fibromyalgia;
(ii) a 24-weeks land-based aerobic-strength intervention
training could be as effective as a water-based interven-
tion; and (iii) the exercise training-induced gains would
be partially retained in the intervention groups after the
detraining period such that their physical status will still
be better than that of the control group at this time
point.
Testing the hypothesis
The present study is a RCT (ClinicalTrials.gov ID:
NCT01490281). The Medical Ethics Committee of Hos-
pital Virgen de las Nieves (Granada, Spain) approved the
study design, study protocols and informed consent pro-
cedure. All participants have to provide a written
informed consent. After baseline measurements, they
will be randomly allocated to the usual care (control),
land-based training or water-based group. The
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Page 2 of 11participants will be followed for 24 weeks during the
training interventions and after 12 weeks of training ces-
sation. All the baseline and follow-up examinations will
be performed in the same setting (local association of
fibromyalgia patients) and by the same investigators.
The study will be performed following the ethical guide-
lines of the Declaration of Helsinki, last modified in
2000.
Participants and selection criteria
Women with fibromyalgia will be recruited from the
local associations of fibromyalgia patients in Andalucía
(Southern Spain). Before starting the study, a screening
will be performed of all candidates. The inclusion and
exclusion criteria for the study are shown in Table 1.
Sample size
The required sample size was determined for the pri-
mary outcome variable, i.e. overall score of Fibromyalgia
Impact Questionnaire (FIQ) [30]. According to previous
research [31], a clinically relevant change is a 15-20%
reduction in the total FIQ score (which equals to a ~10-
15 points reduction). Assuming an unilateral alternative
(i.e. the intervention reduces impact of fibromyalgia), we
can detect differences of at least 15% with a power of
95% and a of 0.05 with two groups (intervention and
usual care group) of 45 participants, with a mean in the
FIQ of ~70 and a standard deviation of ~20 points.
Assuming a maximum lost of follow-up of 30%, we will
recruit a total of 60 women with fibromyalgia for each
group. Since we will develop two types of interventions
(land and water-based), we will recruit a total of 180
women with fibromyalgia (i.e., two intervention groups
and one usual care group of 60 persons each). Figure 1
shows the flow diagram of the study participants
Randomisation and blinding
The participant randomisation assignment will follow an
allocation concealment process, that is, the researcher in
charge of randomly assigning participants will not know
in advance which treatment the next person would
receive and will not participate in assessment. Assess-
ment staff will be blinded to participant randomisation
assignment. Participants will be explicitly informed on
the group to which they will be assigned as well as on
the study hypotheses and will be reminded not to dis-
cuss their randomisation assignments with assessment
staff. It will not be possible to conceal the group assign-
ment from the staff involved in the training.
Statistical analysis
For between groups comparisons at baseline (usual care
vs water-based intervention vs land-based intervention),
we will analyse continuous variables with one-way analy-
sis of variance or the non-parametric method of Krus-
kall-Wallis, and Chi-square tests (or exact techniques if
needed). We will use analysis of covariance (ANCOVA)
to assess the training effects on the primary and second-
ary study outcomes (or the rank-transform ANCOVA).
Age and baseline level of each outcome variable will be
entered as covariates. For each outcome variable we will
report the effect size and the level of significance corre-
sponding to the main group (between-subjects), time
(within-subjects) and interaction (group × time) effects.
We will adjust multiple comparisons for mass signifi-
cance [32]. We will also examine the differences
between drop-outs and participants who remain in the
study. We will analyse the data according to the inten-
tion-to-treat principle [33]. We will handle missing data
due to drop-outs or non-compliance using multiple
imputation methods. To fully appreciate the potential
Table 1 Inclusion and exclusion criteria in the al-Andalus physical activity trial
Inclusion criteria Exclusion criteria
- Age: 35-65 years. - Acute or terminal illness.
- To be diagnosed with fibromyalgia by a rheumatologist and meeting the
American College of Rheumatology criteria: widespread pain for more than 3
months, and pain with 4 kg/cm of pressure reported for 11 or more of 18 tender
points [6].
- Myocardial infarction in the past 3 months.
- Not to have other severe somatic or psychiatric disorders, or other diseases that
prevent physical loading (Answer “no” to all questions on the Physical Activity
Readiness Questionnaire-PAR-Q [29]).
- Unstable cardiovascular disease or other medical condition.
- Not to be engaged in regular physical activity > 20 min on > 3 days/week in the
past 3 months.
- Upper or lower extremity fracture in the past 3 months.
- Planning to stay in the same Association during the study. - Unwillingness to either complete the study requirements or
to be randomised into control or training group.
- Able to ambulate without assistance. - Severe dementia (MMSE < 10)
- Able to communicate. - Presence of neuromuscular disease or drugs affecting
neuromuscular function.
- Informed consent: Must be capable and willing to provide consent. - To be engaged in other physical or psychological treatment.
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ity analysis. In all analyses, we will study the effect of
the regression towards the mean.
Interventions
The interventions will be performed in waves so that
each wave will have between 10 and 12 participants in
the intervention groups, and 10-12 in the usual care
group. The land-based and water-based intervention
groups will train 3 days/week (60 min per session) for a
24-week period. The intervention will involve exercises
for improving cardiovascular endurance, muscle
strength, and joint range of motion. The exercise inter-
ventions will meet the minimum training standards of
the American College of Sports Medicine [34]. The
exercise sessions will be carefully supervised by an exer-
cise monitor.
The exercises will involve all major muscle groups.
During the first weeks, the main part of the sessions will
focus on teaching the patients how to perform the exer-
cises. Each session will include 10 min of warm-up with
slow walks and mobility exercises, followed by 35-40
min of aerobic exercises, developed progressively at
intensity sufficient to achieve 50% (at the beginning of
the intervention) and ~80% (the last month of the inter-
vention) of predicted maximum heart rate (209-0.73 ×
age), and resistance strength training. Finally, each ses-
sion will end with 10 min of cooling down with low-
intensity, flexibility and relaxation exercises.
Heart rate will be assessed with a heart rate monitor
(Polar Electro OY, Finland) in order to control the
intensity of the sessions. One third of the patients in the
intervention group will wear heart rate monitors in 1/3
of the sessions, both randomly selected. We will also
monitor the rate of perceived exertion (RPE) using the
Borg’s conventional (6-20 point) scale [35]. Intensity
(expressed as RPE) will range from 12 to 14. These RPE
values correspond to a subjective perceived exertion of
“light” and “somewhat hard” respectively. Overexertion
will be checked by the “Talk test”, that is, during exer-
cise sessions participants will be able to maintain a con-
versation without getting breathlessness [36].
Recruiting participants 
aged 35-65 years
Training group water-based (n=60) Usual care group (n=60)
Checking eligibility criteria
Orientation and informed consent
Baseline examination (month 0)
Randomisation (n=180)
Post-training examination (Month 6)
Follow up examination (Month 9)
Training group land-based (n=60)
Figure 1 Flow diagram of the study participants.
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The land-based exercise intervention group will train in
the exercise training facilities of the local association of
fibromyalgia, or in the closer exercise centre. Cardiovas-
cular exercises will incorporate walking at different
speeds and continuous and rhythmic activities that
affects large muscle groups and aerobic dance. Resis-
tance strength training will include 1-3 set of 8-12 repe-
titions. The strengthening exercises will include biceps
curls, arm extensions, arm side lifts, shoulder elevations,
lateral leg elevations, stands up from seated position,
lunge, sideways lunge and step-up/step-down. The load
will be gradually increased as the strength of each per-
son improves. We will use body weight at the start of
the program and barbells (0.5-2 kg per exercise). Flex-
ibility will be developed by static stretching at the end
of the warm-up and cool-down periods.
Water-based intervention
The water-based exercise intervention group will train
in a chest-high warm (~30°C) pool. A modified version
of the land-based intervention, adapted to the restric-
tions and peculiarities imposed by water, will be used.
The training intensity and the muscle groups activated
will be as similar as possible in the two groups.
The cardiovascular exercises will include bicycling
simulation (with the floater between legs), walking
around the pool, continuous and rhythmic activities that
affects large muscle groups and aerobic dance. The
strength exercises will be performed at slow pace using
water and aquatic materials as resistance. Flexibility
exercises will consist of static stretching at the end of
the warm-up and cool-down, as in the land-based
intervention.
Usual care group (control)
Participants randomly assigned to the usual care (con-
trol) group will receive general advices from the exercise
monitor about the positive effects of physical activity.
We will prepare informative pamphlets describing the
benefits of physical activity and general guidelines about
how to increase the daily physical activity levels.
Participant retention and adherence
To maximize adherence, several strategies will be imple-
mented including music in all sessions, individualized
attention at the intervention sessions, telephone calls
following missed sessions, and the control of patients’
pain rate before and after each session. Make-up ses-
sions will be allowed in case of missing sessions (due to
illness or any other reason).
Primary outcomes measures
Fibromyalgia Impact Questionnaire (FIQ) is a self-admi-
nistered questionnaire, comprising 10 subscales of dis-
abilities and symptoms (physical function, work missed
day, job ability, feel good, pain, fatigue, sleep, stiffness,
anxiety and depression) and has been validated for
Spanish fibromyalgia patients [30]. The total scores
range from 0 to 100, with a higher score indicating
greater effect of the condition on the person’s life.
Secondary outcomes measures
Tenderness and pain related measures
We will assess 18 tender points according to the Ameri-
can College of Rheumatology criteria for classification of
fibromyalgia using a standard pressure algometer (FPK
20; Effegi, Alfonsine, Italy). The tender point count, total
count of positive tender points, will be recorded for
each participant. The algometer score will be calculated
as the sum of the minimum pain-pressure values
obtained for each tender point.
The Visual analogic scale for pain is a simple assess-
ment tool consisting of a 10 cm line with 0 on one end,
representing no pain, and 10 on the other, representing
the worst pain ever experienced, which a patient marks
to indicate the severity of her pain in the present
moment. This scale will also be administered before and
after each session during the intervention, to assess the
acute effect of exercise on pain.
The Pain Catastrophizing Scale [37,38] will be used to
assess three factors: rumination, magnification and help-
lessness associated to pain. It includes 13 items mea-
sured on a 5-point Likert scale ranging from 0 (not at
all) to 4 (all the time). Higher scores indicate a greater
tendency to catastrophize pain symptoms.
The Chronic Pain Self-Efficacy Scale [39,40], is a scale
that measures efficacy expectations for coping with pain.
It contains 22 items grouped into 3 subscales: self effi-
cacy for pain management, self efficacy for coping with
symptoms, and self efficacy for physical function. The
scores are obtained by means of a Likert scale with a
range of 0-10, where higher scores indicate better self
efficacy.
Body composition
Weight and height will be measured, body mass index
[weight (kg)/height(m
2)] will be calculated, and skeletal
muscle mass, total body water and fat free mass will be
estimated with bioelectrical impedance analysis (InBody
R20; Biospace, Gateshead, UK).
Functional capacity
Participants’ functional capacity will be assessed by field-
based fitness tests following the standardised Functional
Senior Fitness Test Battery [41]. This battery assesses
muscular strength, flexibility, balance and aerobic capa-
city by means of the following tests:
L o w e rb o d ym u s c u l a rs t r e n g t hThe “30-s chair stand
test” involves counting the number of times within 30 s
that an individual can rise to a full stand from a seated
position with back straight and feet flat on the floor,
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perform one trial after familiarization [41].
U p p e rb o d ym u s c u l a rs t r e n g t hThe “Arm curl test”
involves determining a number of times a hand weight
(2.3 kg for women) can be curled through a full range
of motion in 30 s [41]. Additionally, handgrip strength
will be measured using a digital dynamometer (TKK
5101 Grip-D; Takey, Tokyo, Japan) as described else-
where [42]. Patients will perform (alternately with both
hands) the test twice allowing a 1-min rest period
between measures. The best value of 2 trials for each
hand will be chosen and the average of both hands will
be used in the analyses.
Lower body flexibility In the “chair sit and reach test”,
the patient seated with one leg extended, slowly bends
forward sliding the hands down the extended leg in an
attempt to touch (or pass) the toes. The number of cen-
timeters short of reaching the toe (minus score) or
reaching beyond it (plus score) will be recorded [41].
Two trials with each leg will be measured and the best
value of each leg will be registered, and the average of
both legs will be used in the analyses.
Upper body flexibility The “back scratch test”,am e a -
sure of overall shoulder range of motion, involves mea-
suring the distance between (or overlap of) the middle
fingers behind the back with a ruler [41]. Participants
will perform this test twice, alternately with both hands,
and the best value will be registered. The average of
both hands will be used in the analyses.
Motor agility/dynamic balance The “8f tu pa n dg o
test” involves standing up from a chair, walking 8 ft to
and around a cone, and returning to the chair in the
shortest possible time [41]. The best time of two trials
will be recorded and used in the analyses.
Cardiorespiratory fitness We will use the “6-min walk
test”. This test involves determining the maximum dis-
tance (meters) that can be walked in 6 min along a 45.7
m rectangular course [41,43].
The International Fitness Scale [44] is composed of
five Likert-scale questions asking about the perceived
patients’ overall fitness, cardio-respiratory fitness, mus-
cular fitness, speed-agility and flexibility in comparison
with their friends’ physical fitness ("very poor”, “poor”,
“average”, “good” and “very good”).
Physical activity and sedentary behaviour
Physical activity and sedentary behaviour will be objec-
tively (i.e. accelerometry) and subjectively (i.e. question-
naires) assessed:
Accelerometry Women will be asked to wear an tri-axial
accelerometer (ActiGraph GT3X+, Pensacola, Florida,
US) for 8 consecutive days, starting the same day they
receive the monitor, and will returned the acceler-
ometers to the researcher 9 days later. Participants will
be instructed to wear the accelerometer on their lower
back attached by an elastic belt during waking as well as
sleeping hours. For security reasons, participants will be
asked to take them off while bathing.
We will exclude from the analyses bouts of 60 contin-
uous minutes of 0 activity intensity counts, considering
these periods as non-wearing time. Monitor wearing
time will be calculated by subtracting the non-wear time
and the sleeping time (recorded through a diary) from
the total registered time for the entire day (typically
1,440 min). A recording of more than 20,000 counts per
minute will be considered as a potential malfunction of
the accelerometer and the value will be excluded from
the analyses. The first day of recording will not be
included in the analysis. A total of 7 days of recording
with a minimum of ten or more hours of registration
per day will be necessary to be included in the study.
Physical activity levels will be shown as follows: (i) aver-
age physical activity, expressed as mean counts per min-
ute. It is a measure of overall physical activity. We will
calculate mean counts per minute by dividing the sum
of total counts per epoch for a valid day by the number
of minutes of wear time in that day across all valid days.
We will also calculate the time engaged in light, lifestyle,
moderate, and moderate and vigorous intensity physical
activity based upon a standardized cut-off of 100-759,
760-1,951, 1,952-5,724, and at least 1,952 counts per
minute, respectively. Sedentary time will be calculated as
the amount of time accumulated below 100 counts per
minute during periods of wear time.
The Leisure time physical activity instrument [45,46] is
composed of 4 items with 3 activity levels: light, moder-
ate, and vigorous (a short description of each category
will be presented). Patients will be asked to recall the
average number of hours a week during the previous 4
weeks that they had spent engaged in a particular type
of physical activity and at what activity level. The scale
will be simplified into the following 3 levels: (1) 0.5-1.5
h a week, (2) 2-4 h a week, and (3) more than 4 h a
week, and the patient will be asked to provide answers
in hours. The number of hours indicated by the patient
for each intensity category will be summed to obtain the
leisure time physical activity level for 1 week.
The Physical activity at homework or workplace instru-
ment [45,46] is composed of 7 items with 3 categories
for work performed at home (light, moderate and heavy
activity) and 4 categories for employment (sedentary,
light, moderate and heavy activity).The hours for each
category will be summed to obtain the total score.
The Sedentary Behavior Questionnaire [47] consisted
of reports of time spent in 9 sedentary behaviors
(watching television, sitting while playing computer/
video games, sitting while listening to music, sitting and
talking on the phone, doing paperwork or office work,
sitting and reading, playing a musical instrument, doing
Carbonell-Baeza et al. BMC Musculoskeletal Disorders 2012, 13:18
http://www.biomedcentral.com/1471-2474/13/18
Page 6 of 11arts and crafts, sitting and driving/riding in a car, bus, or
train).
The short version of the ALPHA Environmental ques-
tionnaire [48,49] will be used to assess the environmen-
tal perceptions physical activity. The questionnaire will
provide information about types of residences in the
neighborhood, distances to local facilities, walking or
cycle infrastructure in the neighborhood, cycling and
walking network, neighborhood safety, home and work/
study environment mode of active travel.
Fatigue
The Multidimensional Fatigue Inventory [50], that will
be used to measure fatigue severity, comprises five sub-
scales: general fatigue, physical fatigue, mental fatigue,
reduced activity, and reduced motivation [2]. Each sub-
scale includes four items with five-point Likert scales.
General fatigue includes general statements about fati-
gue and decreased functioning and is designed to
encompass both physical and psychological aspects of
fatigue. Physical fatigue concerns physical sensations
related to fatigue. Mental fatigue pertains to cognitive
functioning, including difficulty concentrating. Reduced
activity refers to the influence of physical and psycholo-
gical factors on the level of activity. Reduced motivation
relates to lack of motivation for starting any activity.
Scores on each subscale range from 4 to 20, with higher
scores indicating greater fatigue.
Sleep quality
The Pittsburgh Sleep Quality Index [51] will be used to
assess sleep quality and disturbances over a l-month
time interval. Nineteen individual items generate seven
“component” scores: subjective sleep quality, sleep
latency, sleep duration, habitual sleep efficiency, sleep
disturbances, use of sleeping medication, and daytime
dysfunction. The sum of scores for these seven compo-
nents yields one global score. This test has been used in
previous studies in fibromyalgia patients [52,53].
Health-related quality of life
We will determine patients’ quality of life with the
Short-Form Health Survey 36 (SF-36) [54]. The SF-36 is
a generic instrument for assessing health-related quality
of life. It contains 36 items grouped into 8 dimensions:
physical functioning, physical role, body pain, general
health, vitality, social functioning, emotional role, and
mental health. The scores range from 0 to 100 in every
dimension, where higher scores indicate better health.
The Beck Depression Inventory-II [55,56] will be used
to assess depression severity. It contains 21 items and
the range of score is 0-63 with higher score indicating
greater depression.
The State Trait Anxiety Inventory-I [57] will be used
to assess the level of current anxiety. It is a 20-item self-
administered questionnaire; the range of score is 20-80,
with higher scores indicating a greater state of anxiety.
Positive health will be assessed by means of the fol-
lowing questionnaire:
The Trait Meta-Mood Scale [58], is comprised of
t h r e es u b s c a l e sa n dw ew i l lu s eo n l yo n eo ft h e m ,
the mood repair scale (8 items), that assesses how
well individuals regulate their moods and repair
negative emotional experiences (e.g. “when I become
upset, I remind myself of all the pleasures in life”).
Participants rate their responses using a 5-point
Likert type scale, with 1 = “strongly disagree” to 5 =
“strongly agree”.
The Positive and Negative Affectivity Schedule
[59,60] is a 20-item questionnaire designed to mea-
sure positive and negative affectivity. The question-
naire includes 10 positive and 10 negative emotional
states that should be answered on a 5-point Likert
scale. The negative and positive subscales represent
two relatively independent scales.
The Satisfaction With Life Scale [61,62] designed to
assess global life satisfaction. The SWLS consists of
five items with a 7-point Likert-scale from “strongly
disagree” to “strongly agree”. Higher scores reflect
greater subjective well-being.
The Life Orientation Test Revised [63,64], is a 10-item
scale that assesses subjects’ expectations about their
future and their general sense of optimism. It is com-
prised of 3 positively worded (e.g., “I’m always opti-
mistic about my future”), 3 negatively worded items
(e.g. “I hardly ever expect things to go my way”)a n d
the other 4 are filler questions. Each item is rated on
a five-point Likert type scale ranging from one
("strongly disagree”) to five ("strongly agree”). The
higher the score obtained in the test, the higher the
level of dispositional optimism is and vice-versa.
Cognitive function
The Mini Mental State Examination (MMSE) [65] will
be used to evaluate cognitive capacity and severity of
dementia for the exclusion criteria. The MMSE is a
brief cognitive screening test. The MMSE asks questions
that assess five areas of cognitive functioning: orienta-
tion, immediate memory, attention/concentration,
delayed recall and language.
The Paced Auditory Serial Addition Task [66] will be
used to measure sustained and divided attention, audi-
tory information processing speed, and stimulus compe-
tition filtering skill. In this study, it will be administered
only at the slowest presentation rate of 2.4 s. The score
is the number of correct responses over 60 trials.
The Rey Auditory Verbal Learning Test [67] measures
immediate free recall, delayed free recall, delayed recog-
nition, and verbal learning. This is a multiple-trial verbal
list learning test and will be given on an individual basis.
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Page 7 of 11Patient global impression of change
We will also assess the patients’ perception of change
after the exercise interventions with Patient Global
Impression of Improvement scale [68]. This is a scale
used by patients to report their overall assessment of
change during a clinical trial that uses a 7-point rating
scale with the options “very much improved”, “much
improved”, “minimally improved”, “no change”, “mini-
mally worse”, “much worse” and “very much worse”.
Assessment
The outcomes will be assessed just before the intervention
(baseline), after 24 weeks of exercise interventions (post-
intervention) and after 12 weeks of training cessation
(detraining). The assessments of the primary and second-
ary outcomes will be performed on two separate days in
order to prevent fatigue in the patients. The patients will
complete some questionnaires at home between day 1 and
2. The study assessment schedule is shown in Table 2.
Table 2 Study Assessment Schedule
Assessment Screening Baseline Intervention Post-intervention (24
weeks)
Detraining (12
weeks)
- Informed Consent X
Day 1 testing
- Sociodemographic data X X X
- Mini Mental State Examination X
- Physical Activity Readiness Questionnaire-PAR-Q X
- Beck Depression Inventory-II X X X
- Tender points X X X
- Visual analogic scale for pain X X X X
Questionnaires to complete at home between day 1 and
2
- Fibromyalgia Impact Questionnaire X X X
- Short-Form Health Survey 36 X X X
- State Trait Anxiety Inventory-I X X X
- Trait Meta-Mood Scale X X X
- Positive and Negative Affectivity Schedule X X X
- Satisfaction With Life Scale X X X
- Life Orientation Test Revised X X X
- Pittsburgh Sleep Quality Index X X X
- Multidimensional Fatigue Inventory X X X
- ALPHA Environmental questionnaire X X X
- Sedentary Behavior Questionnaire X X X
- Physical activity at homework or workplace
instrument
XX X
- Leisure time physical activity instrument X X X
- International Fitness Scale X X X
- Chronic Pain Self-Efficacy Scale X X X
- Pain Catastrophizing Scale X X X
Day 2 testing
- Paced Auditory Serial Addition Task X X X
- Rey Auditory Verbal Learning Test X X X
- Body composition X X X
- Chair sit and reach test X X X
- Back scratch test X X X
- Arm curl test X X X
- 30-s chair stand test X X X
- 8 ft up and go test X X X
- Handgrip strength X X X
- 6-min walk test X X X
- Accelerometry (1 week) X X X
- Patient Global Impression of Improvement scale X
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Page 8 of 11Familiarization and reliability assessment
Before the start of the study all patients will have a
familiarization period with all the functional capacity
tests, consisting of two ~50-min sessions. Each session
will be preceded by a warm-up and will end with a
cool-down of the same activities and duration used dur-
ing the training period. Each familiarization session will
consist of 2-3 sets of 1-3 repetitions of the exercises.
We will also assess test-retest reliability (2-weeks apart)
of the study functional capacity tests in a sub-sample.
The tests will be performed by trained and qualified
researchers.
Assessment of side effects
We will record adverse effects or health problems attri-
butable to the testing sessions or intervention sessions,
including muscle pain, fatigue, and general aches and
pains by self-report during the study period. An inde-
pendent researcher will be in charge of auditing all
assessment staff to record all these events in the partici-
pants over the study period.
Implications of the hypothesis
The al-Andalus physical activity RCT will investigate
the effects of 24-week land- and water-based exercise
interventions on disease impact, tenderness, body com-
position, functional capacity, quality of life and cogni-
tive function in female patients with fibromyalgia. Both
exercise interventions will include aerobic, strengthen-
ing and flexibility exercises. We will also assess the
effect of a 3-month detraining period on the study pri-
mary and secondary outcomes. To our knowledge, this
is the largest study specifically designed to compare
the effect of a water-based and land-based exercise
interventions on fibromyalgia patients. Our study
attempts to reduce impact of fibromyalgia and improve
patients’ health status and quality of life by implement-
ing two types of exercise interventions. Results from
this study will help to better assess the potential of
exercise interventions in the treatment of fibromyalgia.
If the interventions proved to be effective and safe, this
study would provide low-cost and feasible alternatives
for health professionals in the management of
fibromyalgia.
Abbreviations
ANCOVA: Analysis of covariance; FIQ: Fibromyalgia impact questionnaire;
MMSE: Mini Mental State Examination; PAR-Q: Physical Activity Readiness
Questionnaire; RCT: Randomised controlled trial; RPE: Rate of perceived
exertion; SF-36: Short-form 36 items.
Acknowledgements
This study was supported by the Consejeria de Turismo, Comercio y Deporte
(CTCD-201000019242-TRA), the Spanish Ministry of Science and Innovation (I
+ D + I DEP2010-15639, grants: BES-2009-013442, BES-2011-047133, RYC-
2010-05957, RYC-2011-09011), the Swedish Heart-Lung Foundation
(20090635), the Spanish Ministry of Education (AP-2009-3173), Granada
Research of Excelence Initiative on Biohealth (GREIB), Campus BioTic,
University of Granada, Spain and European University of Madrid. Escuela de
Estudios Universitarios Real Madrid. 2010/04RM.
Author details
1Department of Physical Education and Sport, School of Sport Sciences,
University of Granada, Granada, Spain.
2Department of Physical Education,
School of Education, University of Cadiz, Cadiz, Spain.
3Department of
Biosciences and Nutrition at NOVUM, Unit for Preventive Nutrition, Karolinska
Institutet, Huddinge, Sweden.
4Department of Physiology, School of
Pharmacy, University of Granada, Granada, Spain.
5Deparment of Physical
Education and Sports, University Pablo de Olavide, Seville, Spain.
6Department of Didactics for Language and Literature, Social Science and
Physical and Sports Education, University of Almeria, Almeria, Spain.
7Department of Physical Education, Music and Arts, University of Huelva,
Huelva, Spain.
8Department of Didactics of Music, Plastic and Corporal
Expression, University of Jaen, Jaen, Spain.
9Department of Psychology,
University of Jaen, Jaen, Spain.
10Biostatistics, School of Medicine, University
of Granada, Granada, Spain.
11Department of Biomedicine, European
University of Madrid, Madrid, Spain.
Authors’ contributions
ACB, JRR, VAA and MDF conceived the study, and participated in its design.
ACB, JRR and VAA drafted the manuscript. FBO, DM, VS, AR, FE, BS, AJC, AS,
PL, MP, PF, IJP, PC, MJG, PT and AL participated in the study design and
critically revised the manuscript. ICA, DC and BS participated in the study
design, critically revised the manuscript, supervised and design the exercise
interventions. PF participated in the study design and provided statistical
support. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 December 2011 Accepted: 15 February 2012
Published: 15 February 2012
References
1. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M,
Saraiva F, Nacci F, Thomas E, Caubere JP, et al: Prevalence of fibromyalgia:
a survey in five European countries. Semin Arthritis Rheum 2010,
39(6):448-453.
2. Mas AJ, Carmona L, Valverde M, Ribas B: Prevalence and impact of
fibromyalgia on function and quality of life in individuals from the
general population: results from a nationwide study in Spain. Clin Exp
Rheumatol 2008, 26(4):519-526.
3. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F: Treatment strategy
in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum
2008, 37(6):353-365.
4. Mork PJ, Vasseljen O, Nilsen TI: Association between physical exercise,
body mass index, and risk of fibromyalgia: longitudinal data from the
Norwegian Nord-Trondelag Health Study. Arthritis Care Res (Hoboken)
2010, 62(5):611-617.
5. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L: An internet survey of
2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007, 8:27.
6. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL,
Tugwell P, Campbell SM, Abeles M, Clark P, et al: The American College of
Rheumatology 1990 criteria for the classification of fibromyalgia. Report
of the multicenter criteria committee. Arthritis Rheum 1990, 33(2):160-172.
7. Wilson HD, Robinson JP, Turk DC: Toward the identification of symptom
patterns in people with fibromyalgia. Arthritis Rheum 2009, 61(4):527-534.
8. Wolfe F, Michaud K, Li T, Katz RS: Chronic conditions and health problems
in rheumatic diseases: comparisons with rheumatoid arthritis,
noninflammatory rheumatic disorders, systemic lupus erythematosus,
and fibromyalgia. J Rheumatol 2010, 37(2):305-315.
9. Lachaine J, Beauchemin C, Landry PA: Clinical and economic
characteristics of patients with fibromyalgia syndrome. Clin J Pain 2010,
26(4):284-290.
10. Gormsen L, Rosenberg R, Bach FW, Jensen TS: Depression, anxiety, health-
related quality of life and pain in patients with chronic fibromyalgia and
neuropathic pain. Eur J Pain 2010, 14(2):127, e121-128.
Carbonell-Baeza et al. BMC Musculoskeletal Disorders 2012, 13:18
http://www.biomedcentral.com/1471-2474/13/18
Page 9 of 1111. Verbunt JA, Pernot DH, Smeets RJ: Disability and quality of life in patients
with fibromyalgia. Health Qual Life Outcomes 2008, 6:8.
12. Henriksson C, Gundmark I, Bengtsson A, Ek AC: Living with fibromyalgia.
Consequences for everyday life. Clin J Pain 1992, 8(2):138-144.
13. Valim V, Oliveira LM, Suda AL, Silva LE, Faro M, Neto TL, Feldman D,
Natour J: Peak oxygen uptake and ventilatory anaerobic threshold in
fibromyalgia. J Rheumatol 2002, 29(2):353-357.
14. Valkeinen H, Hakkinen A, Alen M, Hannonen P, Kukkonen-Harjula K,
Hakkinen K: Physical fitness in postmenopausal women with
fibromyalgia. Int J Sports Med 2008, 29(5):408-413.
15. Jones KD, Horak FB, Winters-Stone K, Irvine JM, Bennett RM: Fibromyalgia is
associated with impaired balance and falls. J Clin Rheumatol 2009,
15(1):16-21.
16. Panton LB, Kingsley JD, Toole T, Cress ME, Abboud G, Sirithienthad P,
Mathis R, McMillan V: A comparison of physical functional performance
and strength in women with fibromyalgia, age- and weight-matched
controls, and older women who are healthy. Phys Ther 2006,
86(11):1479-1488.
17. Heredia Jimenez JM, Aparicio Garcia-Molina VA, Porres Foulquie JM,
Delgado Fernandez M, Soto Hermoso VM: Spatial-temporal parameters of
gait in women with fibromyalgia. Clin Rheumatol 2009, 28(5):595-598.
18. Carbonell-Baeza A, Aparicio VA, Sjostrom M, Ruiz JR, Delgado-Fernandez M:
Pain and functional capacity in female fibromyalgia patients. Pain Med
2011, 12(11):1667-1675.
19. Jones J, Rutledge DN, Jones KD, Matallana L, Rooks DS: Self-assessed
physical function levels of women with fibromyalgia: a national survey.
Womens Health Issues 2008, 18(5):406-412.
20. Thomas EN, Blotman F: Aerobic exercise in fibromyalgia: a practical
review. Rheumatol Int 2010, 30(9):1143-1150.
21. Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD,
Overend TJ, Richards RS, Sawant A, Schachter CL: Exercise therapy for
fibromyalgia. Curr Pain Headache Rep 2011, 15(5):358-367.
22. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL: Exercise for
treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007, 4:
CD003786.
23. Kelley GA, Kelley KS, Hootman JM, Jones DL: Exercise and global well-
being in community-dwelling adults with fibromyalgia: a systematic
review with meta-analysis. BMC Publ Health 2010, 10(1):198.
24. Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ,
Casimiro L, Robinson VA, McGowan J, Busch A, et al: Ottawa Panel
evidence-based clinical practice guidelines for aerobic fitness exercises
in the management of fibromyalgia: part 1. Phys Ther 2008, 88(7):857-871.
25. Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ,
Casimiro L, Robinson VA, McGowan J, Busch A, et al: Ottawa Panel
evidence-based clinical practice guidelines for strengthening exercises
in the management of fibromyalgia: part 2. Phys Ther 2008, 88(7):873-886.
26. Hauser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M,
Busch A: Efficacy of different types of aerobic exercise in fibromyalgia
syndrome: a systematic review and meta-analysis of randomised
controlled trials. Arthritis Res Ther 2010, 12(3):R79.
27. Cazzola M, Atzeni F, Salaffi F, Stisi S, Cassisi G, Sarzi-Puttini P: Which kind of
exercise is best in fibromyalgia therapeutic programmes? A practical
review. Clin Exp Rheumatol 2010, 28(6 Suppl 63):S117-S124.
28. Jentoft ES, Kvalvik AG, Mengshoel AM: Effects of pool-based and land-
based aerobic exercise on women with fibromyalgia/chronic widespread
muscle pain. Arthritis Rheum 2001, 45(1):42-47.
29. Cardinal BJ, Esters J, Cardinal MK: Evaluation of the revised physical
activity readiness questionnaire in older adults. Med Sci Sports Exerc 1996,
28(4):468-472.
30. Rivera J, Gonzalez T: The Fibromyalgia impact questionnaire: a validated
Spanish version to assess the health status in women with fibromyalgia.
Clin Exp Rheumatol 2004, 22(5):554-560.
31. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB: Minimal
clinically important difference in the fibromyalgia impact questionnaire.
J Rheumatol 2009, 36(6):1304-1311.
32. Holm S: A simple sequentially rejective multiple test procedure. Scand J
Statist 1979, 6:65-70.
33. Hollis S, Campbell F: What is meant by intention to treat analysis? Survey
of published randomised controlled trials. BMJ 1999, 319(7211):670-674.
34. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM,
Nieman DC, Swain DP: American College of Sports Medicine position
stand. Quantity and quality of exercise for developing and maintaining
cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently
healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc
2011, 43(7):1334-1359.
35. Borg GA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc
1982, 14(5):377-381.
36. Persinger R, Foster C, Gibson M, Fater DC, Porcari JP: Consistency of the
talk test for exercise prescription. Med Sci Sports Exerc 2004,
36(9):1632-1636.
37. Sullivan MJL, Bishop S, Pivik J: The pain catastrophizing scale:
development and validation. Psychol Assess 1995, 7:524-532.
38. Garcia Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S:
Validation of the Spanish version of the pain catastrophizing scale in
fibromyalgia. Med Clin (Barc) 2008, 131(13):487-492.
39. Anderson KO, Dowds BN, Pelletz RE, Edwards WT, Peeters-Asdourian C:
Development and initial validation of a scale to measure self-efficacy
beliefs in patients with chronic pain. Pain 1995, 63(1):77-84.
40. Martín-Aragón M, Pastor MA, Rodríguez-Marín J, March MJ, Lledó A, López-
Roig S, Terol MC: Percepción de autoeficacia en dolor crónico:
Adaptación y validación de la Chronic Pain Self-Efficacy Scale. Revista de
Psicología de la Salud 1999, 11:53-75.
41. Rikli RE, Jones J: Development and validation of a functional fitness test
for community residing older adults. J Aging Phys Act 1999, 7:129-161.
42. Ruiz-Ruiz J, Mesa JL, Gutierrez A, Castillo MJ: Hand size influences optimal
grip span in women but not in men. J Hand Surg Am 2002, 27(5):897-901.
43. King S, Wessel J, Bhambhani Y, Maikala R, Sholter D, Maksymowych W:
Validity and reliability of the 6 minute walk in persons with
fibromyalgia. J Rheumatol 1999, 26(10):2233-2237.
44. Ortega FB, Ruiz JR, Espana-Romero V, Vicente-Rodriguez G, Martinez-
Gomez D, Manios Y, Beghin L, Molnar D, Widhalm K, Moreno LA, et al: The
International Fitness Scale (IFIS): usefulness of self-reported fitness in
youth. Int J Epidemiol 2011, 40(3):701-711.
45. Mannerkorpi K, Hernelid C: Leisure time physical activity instrument and
physical activity at home and work instrument. Development, face
validity, construct validity and test-retest reliability for subjects with
fibromyalgia. Disabil Rehabil 2005, 27(12):695-701.
46. Munguia-Izquierdo D, Legaz-Arrese A, Mannerkorpi K: Transcultural
adaptation and psychometric properties of a Spanish-language version
of physical activity instruments for patients with fibromyalgia. Arch Phys
Med Rehabil 2011, 92(2):284-294.
47. Rosenberg DE, Norman GJ, Wagner N, Patrick K, Calfas KJ, Sallis JF:
Reliability and validity of the Sedentary Behavior Questionnaire (SBQ)
for adults. J Phys Act Health 2010, 7(6):697-705.
48. Spittaels H, Foster C, Oppert JM, Rutter H, Oja P, Sjostrom M, De
Bourdeaudhuij I: Assessment of environmental correlates of physical
activity: development of a European questionnaire. Int J Behav Nutr Phys
Act 2009, 6:39.
49. Spittaels H, Verloigne M, Gidlow C, Gloanec J, Titze S, Foster C, Oppert JM,
Rutter H, Oja P, Sjostrom M, et al: Measuring physical activity-related
environmental factors: reliability and predictive validity of the European
environmental questionnaire ALPHA. Int J Behav Nutr Phys Act 2010,
7(1):48.
50. Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue
Inventory (MFI) psychometric qualities of an instrument to assess
fatigue. J Psychosom Res 1995, 39(3):315-325.
51. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh
sleep quality index: a new instrument for psychiatric practice and
research. Psychiatry Res 1989, 28(2):193-213.
52. Bigatti SM, Hernandez AM, Cronan TA, Rand KL: Sleep disturbances in
fibromyalgia syndrome: relationship to pain and depression. Arthritis
Rheum 2008, 59(7):961-967.
53. Munguia-Izquierdo D, Legaz-Arrese A: Assessment of the effects of
aquatic therapy on global symptomatology in patients with fibromyalgia
syndrome: a randomized controlled trial. Arch Phys Med Rehabil 2008,
89(12):2250-2257.
54. Alonso J, Prieto L, Anto JM: The Spanish version of the SF-36 Health
Survey (the SF-36 health questionnaire): an instrument for measuring
clinical results. Med Clin (Barc) 1995, 104(20):771-776.
55. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for
measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
Carbonell-Baeza et al. BMC Musculoskeletal Disorders 2012, 13:18
http://www.biomedcentral.com/1471-2474/13/18
Page 10 of 1156. Beck AT, Steer RA, Brown GK: BDI-II Inventario de depresión de beck.
Buenos Aires: Editorial Paidos; 2006.
57. In STAI: Manual del Cuestionario de Ansiedad Estado-Rasgo. Edited by:
Spielberger CD, Gorsuch RL, Lushene RE. Madrid: TEA Ediciones; 2002:.
58. Fernandez-Berrocal P, Extremera N, Ramos N: Validity and reliability of the
Spanish modified version of the trait meta-mood scale. Psychol Rep 2004,
94(3 Pt 1):751-755.
59. Watson D, Clark LA, Tellegen A: Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc
Psychol 1988, 54(6):1063-1070.
60. Sandín B, Chorot P, Lostao L, Joiner TE, Santed MA, Valiente RM: Escalas
PANAS de afecto positivo y negativo: validación factorial y convergencia
transcultural. Psicothema 1999, 14:333-339.
61. Diener E, Emmons RA, Larsen RJ, Griffin S: The satisfaction with life scale. J
Pers Assess 1985, 49(1):71-75.
62. Atienza FL, Pons D, Balaguer I, García-Merita M: Propiedades Psicométricas
de la Escala de Satisfacción con la Vida en Adolescentes. Psicothema
2000, 12(32):314-319.
63. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from
neuroticism (and trait anxiety, self-mastery, and self-esteem): a
reevaluation of the life orientation test. J Pers Soc Psychol 1994,
67(6):1063-1078.
64. Otero JM, Luengo A, Romero E, Gómez JA, Castro C: Psicología de la
Personalidad Manual de prácticas. Barcelona: Ariel Practicum; 1998.
65. Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical
method for grading the cognitive state of patients for the clinician. J
Psychiatr Res 1975, 12(3):189-198.
66. Gronwall DM: Paced auditory serial-addition task: a measure of recovery
from concussion. Percept Mot Skills 1977, 44(2):367-373.
67. Rey A: L’examen clinique en psychologie Paris: Presse Universitaire de France;
1958.
68. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP,
Kerns RD, Stucki G, Allen RR, Bellamy N, et al: Core outcome measures for
chronic pain clinical trials: IMMPACT recommendations. Pain 2005, 113(1-
2):9-19.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/13/18/prepub
doi:10.1186/1471-2474-13-18
Cite this article as: Carbonell-Baeza et al.: Land- and water-based
exercise intervention in women with fibromyalgia: the al-andalus
physical activity randomised controlled trial. BMC Musculoskeletal
Disorders 2012 13:18.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Carbonell-Baeza et al. BMC Musculoskeletal Disorders 2012, 13:18
http://www.biomedcentral.com/1471-2474/13/18
Page 11 of 11